Data Bridge Market Research recently presented the "Global Dry Eye Syndrome Treatment Market" report which provides reliable and sincere insights related to the various segments and sub-segments of the market. The market study throws light on the various factors that are projected to impact the overall dynamics of the Dry Eye Syndrome Treatment Market over the forecast period (2020-2026).

Pune, India -- (SBWire) -- 02/17/2020 --The global dry eye syndrome treatment market is projected to register a substantial CAGR of 6.8% in the forecast period of 2019 to 2026. Global Dry Eye Syndrome Treatment Market By Product Type (Emulsions, Lubricant Eye Drops/Solutions, Eye Ointments, Autologous Serum Eye Drops, Nutrition Supplements, Others), Disease Type (Evaporative Dry Eye Syndrome, Aqueous Dry Eye Syndrome), Treatment Type (Lubricating Agents, Tear Stimulators, Artificial Tears, Anti-Inflammatory Drugs, Antibiotic Drugs, Others), End-User (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) - Industry Trends and Forecast to 2026

Download exclusive PDF sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-dry-eye-syndrome-treatment-market

Some of the major players operating in this market are Mitotech, SA, Johnson & Johnson Services, Inc., Sun Pharmaceutical Industries Ltd., ALLERGAN, Novaliq GmbH, Prestige Consumer Healthcare, Inc., Horus Pharma, Senju Pharmaceutical Co. Ltd., VISUfarma, Akorn, Incorporated, Bausch & Lomb Incorporated, Teva Pharmaceutical Industries Ltd., Alcon Inc., Santen Pharmaceutical Co., Ltd., Novartis AG, Similasan and others.

Dry eye syndrome is a condition that has an increasing prevalence along with the increasing ages. It is around 50.0% more common in women as compared to men. Dry eye if left untreated can lead to ulcers, pain, scars on the cornea or some loss of the vision. However, the permanent loss of vision due to dry eye is uncommon.

Dry eye syndrome can be associated with:


- Any disease process which helps in altering the components of the tears

- Cosmetic surgery, if eye-lids are opened widely

- Inflammation of surface of the eyes, the conjunctiva or the lacrimal gland

- Growth in the surface of the eyes, as in thyroid diseases when the eyes protrude forward


Segmentation: Global Dry Eye Syndrome Treatment Market

Global dry eye syndrome treatment market is segmented into five notable segments which are product type, disease type, treatment type, end user and distribution channel.


- On the basis of product type, the market is segmented into emulsions, lubricant eye drops/solutions, eye ointments, nutrition supplements, autologous serum eye drops and others.


- In June 2019, Santen Pharmaceutical Co., Ltd. and Oxford Biomedica entered into the R&D collaboration and the Option and License agreement for the advancement of the gene therapy vectors for the inherited retinal diseases. The main aim of this R&D collaboration is of generating pre-clinical proof of the concept for treating the inherited retinal diseases with the lentiviral vectors that is manufactured and developed by OXB. This would help in the product development of the company.




- On the basis of disease type, the market is segmented into evaporative dry eye syndrome and aqueous dry eye syndrome


- In May 2019, Allergan participated at the Bank of America Merrill Lynch 2019 Health Care Conference which was held in Las Vegas on 14th May. This would help the company to enhance its customer base




- On the basis of treatment type, the market is segmented into tear stimulators, lubricating agents, anti-inflammatory drugs, artificial tears, antibiotic drugs and others


- In June 2019, Akorn, Inc. was presented at the Jefferies 2019 Global Healthcare Conference which was held on 7th June in the U.S. This strategy will help the company to give insights regarding their products and increase their customer base.




- On the basis end user, the market is segmented into of home healthcare, hospitals, clinics and others


- In January 2017, Akorn, Inc. was presented at the 35th Annual J.P. Morgan Healthcare Conference which was held on 9th January in the U.S. This strategy will help the company to enhance their customer base and expand its business.




- On the basis of distribution channel, the market is segmented into of hospital pharmacies, retail pharmacies, online pharmacies and others.


- In May 2019, Johnson & Johnson Vision showcase their New Data and Innovations in Eye Care at the 2019 British Contact Lens Association Conference (BCLA) which was held in U.K. from 30th May and 1st June. This would help the company to focus on driving the transformational innovation for improving the vision performance and the comfort for patients across the world.





To Buy Complete Report Click Here @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-dry-eye-syndrome-treatment-market

Recent Developments


- In June 2019, Novartis completed the acquisition of Xiidra from Takeda Pharmaceutical Company Limited. This strategy would help the company to boost their ophthalmic portfolio in the market.

- In June 2019, Allergan participated at the Jefferies 2019 Healthcare Conference which was held in New York on 6th June. This would help the company to enhance its customer base.

- In December 2018, Alcon Inc. acquired Tear Film Innovations, Inc. (U.S.). The major advantage of this acquisition is that it will help Alcon to expand its product portfolio in ocular health products and thus expanded its patient base by providing treatment for dry eye syndrome.


Table of Contents:

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF GLOBAL DRY EYE SYNDROME TREATMENT MARKET

1.4 CURRENCY AND PRICING

1.5 LIMITATIONS

1.6 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GLOBAL DRY EYE SYNDROME TREATMENT MARKET: GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 DBMR MARKET POSITION GRID

2.8 DBMR VENDOR SHARE ANALYSIS

2.9 MULTIVARIATE MODELING

2.1 PRODUCTS LIFELINE CURVE

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING PREVALENCE OF DRY EYE DISEASES

3.1.2 CHANGING GEOGRAPHICAL TRENDS TO DRIVE THE MARKET

3.1.3 INCREASING AWARENESS ABOUT DIAGNOSIS AND TREATMENT OF THE DISEASE

3.1.4 RISING GERIATRIC POPULATION ACROSS THE WORLD

3.1.5 INCREASE IN LASIK SURGERY AND USAGE OF CONTACT LENSES

3.2 RESTRAINTS

3.2.1 STRINGENT REGULATORY PROCESS

3.2.2 UNMET MEDICAL NEEDS

3.3 OPPORTUNITIES

3.3.1 EMERGING MARKET PRESENTS SIGNIFICANT OPPORTUNITIES

3.3.2 DEVELOPMENT OF NOVEL TECHNOLOGIES

3.4 CHALLENGE

3.4.1 INCREASING NUMBER OF PLAYERS

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY PRODUCT TYPE

6.1 OVERVIEW

6.2 EMULSIONS

6.3 LUBRICANT EYE DROPS/SOLUTIONS

6.3.1 OILY TEAR EYE DROP

6.3.2 PRESERVATIVE-FREE DROPS

6.4 EYE OINTMENTS

6.5 NUTRITION SUPPLEMENTS

6.6 AUTOLOGOUS SERUM EYE DROPS

6.7 OTHERS

7 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY DISEASE TYPE

7.1 OVERVIEW

7.2 EVAPORATIVE DRY EYE SYNDROME

7.3 AQUEOUS DRY EYE SYNDROME

8 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY TREATMENT TYPE

8.1 OVERVIEW

8.2 TEAR STIMULATORS

8.3 LUBRICATING AGENTS

8.4 ANTI-INFLAMMATORY DRUGS

8.5 ARTIFICIAL TEARS

8.6 ANTIBIOTIC DRUGS

8.7 OTHERS

9 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY END USER

10 GLOBAL DRY EYE SYNDROME TREATMENTMARKET, BY DISTRIBUTION CHANNEL

11 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, BY GEOGRAPHY

12 GLOBAL DRY EYE SYNDROME TREATMENT MARKET, COMPANY LANDSCAPE

13 COMPANY PROFILES

Get Full TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-dry-eye-syndrome-treatment-market

About Data Bridge Market Research
An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: Corporatesales@databridgemarketresearch.com